This image will be automatically disabled when it gets reported by several people.
Women's entering National medicine industry breaks the barriers of their work in the pharmacies. One thousand Saudis work in 14 factories, and production covers only 23% of the market's need.
A medicine researcher requested the control systems of medicine industry to ensure that the women staff technically meets the conditions of medicine industry that is called GMP. He added that it is necessary to design a certified training program that contributes in decreasing the percentage of career infiltration and supports the experience of having separate production lines that is operated by women in the medicine factory. Pharmacist Abdulrahman Al Sultan, a medicine researcher in medicine management, said that the royal direction from King Abdulla Bin Abdel Aziz "may Allah protect him" comes as a progressive building of real nationalizing for industry and technology, especially in the medicine industry, which is considered to be most of the developed industries worldwide and contributes in building medicine security in the kingdom that prevent it from international instability evil and the hardship of attracting foreign qualifications. The pharmacist pointed that there are separate production lines that are operated by a women staff in multiple medicine and non-medicine factories worldwide although medicine industry is distinguished by it depending widely on advanced technologies. This opens bigger opportunity to train and recruit technical staff that are more productive and qualified. He continued by saying the importance of the royal direction comes under the wide expansion in the pharmacy education in universities in all Kingdom regions through opening pharmacy colleges exceeding fifteen governmental and common colleges. This will provide the local market with a lot of qualified Saudi female pharmacist that are currently facing unemployment due to the nature of their work which concentrates only on hospital pharmacies, pharmacy applications and clinical pharmacy only. He added that the development and training of Saudi staff in this area is a responsibility of pharmacy colleges mainly academic wise, then it is a responsibly of the committees specialized in medicine industry in Saudi Chambers council and Business Chambers in the cities that have medicine industry, training and career wise. Pharmacist Al Sultan encouraged the Ministry of Labor to list the available jobs in the medicine industry within 2 months and to ensure that the work environment meets the conditions and regulations of women work in the private sector. Pharmacist Al Sultan stressed that the nationalizing step of local medicine factories' production lines must be followed by more steps of total progressive nationalism of medicine industry in the Kingdom to reach the goal of Saudi produced medicine industry. The Assistant of General-Secretary of Saudi Chambers Council for National committees Affairs Mshbab Al Saa'd said that the committee proposes that the Saudi medicine products are included within external supporting programs of the countries suffering from natural disasters to support the Saudi medicine exports, as well as helping the national medicine companies in eliminating the obstacles of entering Arab region markets through environmental trading programs with Arab and other countries, especially under the economic and business agreements regionally and internationally to facilitate the exports of national products to those markets after the international trust that Saudi medicine products achieved by its presence in European and American markets. Al Saa'd pointed that the Kingdom acquires a distguished position among the biggest health care markets in the Middle East and Africa, which enhances its position as one of the biggest and fastest growing market by a rate of 10% yearly in the region in the health care sector. It is expected that the market of Saudi medicine only will record a compound annual growth from 7.5%, achieving an increase of 2.65 trillion dollars (10.27 trillion Riyals) in 2008, to 3.49 trillion dollars (13.1 trillion Riyals) in 2013. Saudi medicine market is experiencing a decrease in the role of local medicine factories in meeting the needs of the local market. Although there are 14 medicine factories that produce medicine in the Kingdom but its production covers only 23% of the Saudi market's needs, which means that there is a gap of 80% that is covered by the imports and that activating the royal decisions will contribute in supporting and increasing the national products.